ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study

Luc Dauchet, Marc Lambert, Victoria Gauthier, Julien Poissy, Karine Faure, Alain Facon, Cécile Yelnik, Sophie Panaget, Thierry Plagnieux, Florent Verfaillie, Daniel Mathieu, Patrick Goldstein, Aline Meirhaeghe, Philippe Amouyel on behalf of the Lille COVID-19 study group
doi: https://doi.org/10.1101/2020.04.28.20078071

Data Availability

The data can be obtained by contacting the corresponding author

Back to top
Posted May 01, 2020.
Download PDF
Data/Code
Email
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
Luc Dauchet, Marc Lambert, Victoria Gauthier, Julien Poissy, Karine Faure, Alain Facon, Cécile Yelnik, Sophie Panaget, Thierry Plagnieux, Florent Verfaillie, Daniel Mathieu, Patrick Goldstein, Aline Meirhaeghe, Philippe Amouyel
medRxiv 2020.04.28.20078071; doi: https://doi.org/10.1101/2020.04.28.20078071
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area